REQUEST A DEMO
Total
USD $0.00
Search more companies

Resbiomed OOD (Ресбиомед ООД) (Bulgaria)

Main Activities: Research and Development in Nanotechnology
Full name: Resbiomed OOD Profile Updated: February 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Resbiomed OOD (Ресбиомед ООД) is a company based in Bulgaria, with its head office in Sofia. It operates in the Research and Development in Nanotechnology industry. It was first established on February 25, 2002. 33 (2023) employees currently work for Resbiomed OOD (Ресбиомед ООД). In 2024, the company reported a net sales revenue increase of 40.76%. Its’ total assets recorded a negative growth of 26.31%. In, 2024, the company’s net profit margin increased by 2.49%.

Headquarters
Ul.Pozitano 136A, ET. 1
Sofia; Sofia - city;

Contact Details: Purchase the Resbiomed OOD (Ресбиомед ООД) report to view the information.

Basic Information
Total Employees:
Purchase the Resbiomed OOD (Ресбиомед ООД) report to view the information.
Registered Capital:
Purchase the Resbiomed OOD (Ресбиомед ООД) report to view the information.
Financial Auditors:
Purchase the Resbiomed OOD (Ресбиомед ООД) report to view the information.
Incorporation Date:
February 25, 2002
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Resbiomed OOD (Ресбиомед ООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
40.76%
Total Operating Revenue
41.37%
Operating Profit
51.12%
EBITDA
49.9%
Net Profit/Loss for the Period
46.44%
Total Assets
-26.31%
Total Equity
-27.6%
Operating Profit Margin
4.76%
Net Profit Margin
2.49%
Return on Equity (ROE)
29.65%
Quick Ratio
0.57%
Cash Ratio
-0.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?